Rigel Pharmaceuticals | Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Agenus USD 23.6M 448K 2025-09
Amgen USD 50B 2.43B 2025-12
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 538.1M 323.22M 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 40.87B 6.69B 2025-09
Halozyme Therapeutics USD 800.07M 709.03M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Intrexon USD 0 198.67M 2024-06
Ionis Pharmaceuticals USD 28.78M 596.71M 2025-09
Karyopharm Therapeutics USD -0.93 0.67 2024-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
MacroGenics USD 70.26M 4K 2025-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 782.75M 11.3M 2025-06
Veracyte USD 0 0 2025-03


Rigel Pharmaceuticals Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.